The muscarinic acetylcholine receptor M2 (CHRM2) mediates diverse cellular responses, including the inhibition of adenylate cyclase, phosphoinositide breakdown, and modulation of potassium channels via G protein coupling. Its primary transduction effect is adenylate cyclase inhibition. Signal transduction activates phospholipase C, releasing inositol trisphosphate (IP3), which subsequently triggers cytosolic calcium ion release.
STRING: 9598.ENSPTRP00000054285
The muscarinic acetylcholine receptor M2 (CHRM2) belongs to the G-protein-coupled receptor (GPCR) superfamily and plays crucial roles in neuronal excitability, synaptic plasticity, and feedback regulation of acetylcholine release . In both humans and chimpanzees, the CHRM2 receptor is involved in multiple signaling pathways that modulate neuronal activity. These receptors contribute to learning, memory, and cognitive processes through their role in cholinergic neurotransmission . When designing experiments with Pan troglodytes CHRM2, researchers should account for its involvement in these fundamental neural processes.
CHRM2 is highly conserved between humans and chimpanzees due to their close evolutionary relationship. While the search results don't provide specific sequence homology data for Pan troglodytes CHRM2, researchers should note that functional domains, particularly those involved in ligand binding and G-protein coupling, demonstrate high conservation across primates. Experimental design should account for both the similarities and potential species-specific differences in receptor pharmacology and signal transduction pathways.
Based on available protocols for human CHRM2, prokaryotic expression systems using E. coli have been successfully employed to produce recombinant CHRM2 protein fragments . When expressing Pan troglodytes CHRM2, researchers should consider:
Expression vector selection (vectors with His and TrxA tags have proven effective for human CHRM2)
Buffer optimization (PBS at pH 7.4 containing 0.01% SKL and 5% Trehalose has been used successfully)
Purification strategy (affinity chromatography leveraging His-tag is recommended)
Protein solubility considerations (membrane proteins like CHRM2 often require specialized solubilization methods)
For functional studies, mammalian expression systems may be more appropriate to ensure proper post-translational modifications and membrane insertion.
Multiple complementary approaches should be employed:
SDS-PAGE analysis: Expected molecular mass of approximately 40-45 kDa under reducing conditions, though actual band size may differ from predicted values due to post-translational modifications
Western blotting: Using antibodies specifically validated for CHRM2
Mass spectrometry: For precise molecular characterization and peptide fingerprinting
Functional assays: To confirm biological activity through ligand binding or signaling pathway activation
Researchers should note that discrepancies between predicted and observed molecular weight (as seen with human CHRM2 at 39.8 kDa predicted vs. 43 kDa observed) are common and may result from:
Alternative splicing
Post-translational modifications
Relative charge effects
When designing genotyping protocols for Pan troglodytes CHRM2, researchers should:
Select appropriate SNPs based on conservation with human variants or chimpanzee-specific databases
Implement quality control measures including HWE testing (Hardy-Weinberg Equilibrium)
Consider linkage disequilibrium patterns when selecting tag-SNPs
Ensure high genotyping success rates (>95% as achieved in human studies)
For human CHRM2, researchers have successfully implemented SNPlex genotyping approaches with multiple markers across the gene . Similar strategies can be adapted for Pan troglodytes, with careful attention to species-specific sequence variations. Initial genotyping should focus on exons and regulatory regions that are most likely to affect gene function.
Based on protocols developed for human CHRM2, researchers should consider:
RT-PCR Protocol Recommendations:
Primer design targeting conserved regions between human and chimpanzee CHRM2
PCR conditions: 94°C for 1 min, 64°C for 1 min, and 72°C for 1 min, for 40 cycles, followed by a 10-min extension at 72°C
Optimization of primer concentration and cDNA input with verification via dissociation curves
Use of appropriate housekeeping genes (β-actin and HPRT have been effective for human studies)
When working with Pan troglodytes samples, tissue preservation and RNA extraction quality are critical factors affecting experimental success.
CHRM2 demonstrates complex transcriptional expression patterns with multiple promoters and transcript variants. In humans, at least six different mRNA transcripts (isoforms A-F) encoding the same receptor protein have been identified . To investigate these in Pan troglodytes:
Design primers targeting the unique exons of each transcript variant (similar to those used in human studies: FA&B, FC&D, FE&F with RA-F)
Perform PCR at 94°C for 30 sec, 55°C for 30 sec, and 72°C for 1:30 min, for 40 cycles, followed by a 7-min extension at 72°C
Verify specific amplification products on a 2% agarose gel
Consider quantitative RT-PCR to measure relative expression levels of each transcript
Understanding the distribution of transcript variants may provide insights into tissue-specific regulation of CHRM2 expression in chimpanzees, which could be compared with human expression patterns.
Researchers investigating functional effects of CHRM2 variants should consider:
Gene expression correlation studies: Analyze correlation between SNP genotypes and CHRM2 mRNA levels in relevant tissues
Reporter gene assays: Construct reporter plasmids containing variant sequences to assess their impact on transcriptional activity
Electrophysiological studies: Evaluate effects on neuronal excitability in cellular models
Pharmacological characterization: Assess whether variants alter ligand binding or downstream signaling
Human studies have examined correlations between genetic variants and gene expression levels in brain tissue , providing a methodological framework that can be adapted for Pan troglodytes research.
Designing comparative cognitive studies requires:
Selection of appropriate cognitive tasks: Choose tests that can be administered to both humans and chimpanzees with similar cognitive demands
Genotyping strategy: Target conserved polymorphisms shown to associate with cognitive phenotypes in humans
Statistical approach: Implement linear regression models testing for association between genotype and cognitive measures, controlling for relevant covariates
Cross-species validation: Compare results with published human findings on CHRM2 and intelligence
Human studies have demonstrated associations between CHRM2 variants and intelligence measures , providing potential targets for comparative research with chimpanzees.
Common challenges include:
Protein insolubility: As a membrane protein, CHRM2 may form inclusion bodies in prokaryotic systems. Solutions include:
Molecular weight discrepancies: Like human CHRM2, Pan troglodytes CHRM2 may show differences between predicted and observed molecular weights. Researchers should:
Functional validation: Confirming proper folding and activity requires:
Ligand binding assays with known muscarinic agonists and antagonists
G-protein coupling assays
Second messenger quantification (e.g., calcium mobilization, cAMP inhibition)
When confronted with discrepancies between in vitro and in vivo findings:
Consider system complexity: In vivo systems involve multiple receptor subtypes, compensatory mechanisms, and complex regulatory networks
Evaluate model validity: Assess whether the in vitro system adequately represents the physiological context
Examine species differences: Potential differences in signaling pathways or receptor pharmacology between humans and chimpanzees
Design validation experiments: Use multiple complementary approaches to confirm findings
Researchers should particularly consider the complex transcriptional regulation of CHRM2, with its multiple promoters and tissue-specific expression patterns , when interpreting conflicting results.
While specific comparison data between human and chimpanzee CHRM2 polymorphisms is not provided in the search results, researchers can approach this question through:
Comparative genomic analysis: Identify polymorphic sites that are conserved or divergent between species
Functional prediction: Use in silico tools to predict effects of species-specific variants on protein function or expression
Experimental validation: Test functional differences using recombinant proteins or cell-based assays
Human studies have identified functional variants in non-coding regions (5'UTR, intronic regions) associated with cognitive phenotypes . Similar approaches can be applied to identify and characterize functional variants in Pan troglodytes CHRM2.
CHRM2 presents a valuable model for studying cognitive evolution because:
It has been consistently associated with cognitive abilities in humans
The cholinergic system is fundamental to learning and memory across species
Comparisons between closely related species can reveal selection pressures on cognitive mechanisms
Research approaches should include:
Comparative sequence analysis of regulatory regions
Cross-species phenotype-genotype associations
Functional characterization of species-specific variants
Analysis of expression patterns in homologous brain regions
Human studies showing associations between CHRM2 variants and intelligence provide a foundation for comparative studies investigating cognitive evolution in primates.
Based on human research demonstrating associations between CHRM2 and externalizing behaviors , researchers can:
Define appropriate behavioral measures: Select behaviors that can be reliably assessed in chimpanzees
Implement a longitudinal design: Collect behavioral data across development, as done in human studies
Consider environmental moderators: Test for gene-environment interactions, similar to the parental monitoring interaction found with human CHRM2
Use appropriate statistical models: Implement linear regression models with genotype coded in an additive fashion (0, 1, or 2 copies of the major allele)
The statistical approach used in human studies, controlling for relevant covariates and testing for interaction effects , provides a methodological framework that can be adapted for chimpanzee research.
Human studies have demonstrated that:
Parental monitoring moderates the association between CHRM2 and externalizing behavior
The association between CHRM2 genotype and externalizing behavior is stronger in environments with lower parental monitoring
There is evidence for a crossover effect, where genotypes associated with highest externalizing behavior under low monitoring show lowest levels under high monitoring
For Pan troglodytes research, analogous environmental factors might include:
Social group structure and hierarchy
Maternal care quality
Early life stress
Social enrichment in captive environments
When designing studies to investigate gene-environment interactions in chimpanzees, researchers should consider both measurement of environmental variables and appropriate statistical approaches to test interaction effects.